Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 6
Submit an article Journal homepage
2,325
Views
17
CrossRef citations to date
0
Altmetric
Mini-Review

Vaccinia virus-based vector against infectious diseases and tumors

Ziling Zhanga Shanghai Public Health ClinicalCenter& Institutes of Biomedical Science, Shanghai Medical College, Fudan University, Shanghai, ChinaORCID Iconhttps://orcid.org/0000-0002-4085-4137View further author information
ORCID Icon,
Lanlan Donga Shanghai Public Health ClinicalCenter& Institutes of Biomedical Science, Shanghai Medical College, Fudan University, Shanghai, ChinaView further author information
,
Chen Zhaoa Shanghai Public Health ClinicalCenter& Institutes of Biomedical Science, Shanghai Medical College, Fudan University, Shanghai, ChinaView further author information
,
Peiyong Zhengb Institute of Digestive Diseases, LongHua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaView further author information
,
Xiaoyan Zhanga Shanghai Public Health ClinicalCenter& Institutes of Biomedical Science, Shanghai Medical College, Fudan University, Shanghai, China;c State Key Laboratory for Infectious Disease Prevention and Control, China Centers for Disease Control and Prevention, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Jianqing Xua Shanghai Public Health ClinicalCenter& Institutes of Biomedical Science, Shanghai Medical College, Fudan University, Shanghai, China;c State Key Laboratory for Infectious Disease Prevention and Control, China Centers for Disease Control and Prevention, Beijing, ChinaCorrespondence[email protected]
View further author information
Pages 1578-1585 | Received 18 May 2020, Accepted 18 Oct 2020, Published online: 19 Feb 2021

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

A Daban, C Gonnin, L Phan, A Saldmann, C Granier, A Lillo-Lelouet, C Le Beller, J Pouchot, l Weiss, E Tartour, E Fabre, J Medioni, S Oudard, YA Vano, MA Dragon-Durey & A. Simonaggio. (2023) Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs). OncoImmunology 12:1.
Read now

Articles from other publishers (16)

Dokyun Kim, Chih-Jen Lai, Inho Cha & Jae U. Jung. (2024) Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development. Viruses 16:1, pages 128.
Crossref
Stephen Boulton, Joanna Poutou, Rida Gill, Nouf Alluqmani, Xiaohong He, Ragunath Singaravelu, Mathieu J.F. Crupi, Julia Petryk, Bradley Austin, Leonard Angka, Zaid Taha, Iris Teo, Siddarth Singh, Rameen Jamil, Ricardo Marius, Nikolas Martin, Taylor Jamieson, Taha Azad, Jean-Simon Diallo, Carolina S. Ilkow & John C. Bell. (2023) A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection. Molecular Therapy - Methods & Clinical Development 31, pages 101110.
Crossref
Junior A. Enow, Hummad I. Sheikh & Masmudur M. Rahman. (2023) Tumor Tropism of DNA Viruses for Oncolytic Virotherapy. Viruses 15:11, pages 2262.
Crossref
Paramesh V. Karandikar, Lyle Suh, Jakob V. E. Gerstl, Sarah E. Blitz, Qing Rui Qu, Sae-Yeon Won, Florian A. Gessler, Omar Arnaout, Timothy R. Smith, Pier Paolo Peruzzi, Wei Yang, Gregory K. Friedman & Joshua D. Bernstock. (2023) Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma. Frontiers in Cell and Developmental Biology 11.
Crossref
Simran Deep Kaur, Aman Deep Singh & Deepak N. Kapoor. (2023) Current perspectives on Vaxinia virus: an immuno-oncolytic vector in cancer therapy. Medical Oncology 40:7.
Crossref
Scott Napper & Hermann M. Schatzl. (2023) Oral vaccination as a potential strategy to manage chronic wasting disease in wild cervid populations. Frontiers in Immunology 14.
Crossref
Jana Koch, Julia Beil, Susanne Berchtold, Dina Mönch, Annika Maaß, Irina Smirnow, Andrea Schenk, Mary E. Carter, Linus D. Kloker, Tobias Leibold, Philipp Renner, Marc-H. Dahlke & Ulrich M. Lauer. (2023) Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model. Viruses 15:2, pages 363.
Crossref
Rupsa Basu & Chad M. Moles. 2023. Viral Vectors in Cancer Immunotherapy. Viral Vectors in Cancer Immunotherapy 241 261 .
Min Wei, Shuguang Zuo, Zhimin Chen, Peng Qian, Yenan Zhang, Lingkai Kong, Honglan Gao, Jiwu Wei & Jie Dong. (2022) Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors. Frontiers in Immunology 13.
Crossref
Lilan Xie & Yaoming Li. (2022) Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development. Vaccine 40:49, pages 7022-7031.
Crossref
Léa GaucherandMarta Maria Gaglia. (2022) The Role of Viral RNA Degrading Factors in Shutoff of Host Gene Expression. Annual Review of Virology 9:1, pages 213-238.
Crossref
Xiaoling Cao, Junjie Zai, Qingzhen Zhao, Lilan Xie & Yaoming Li. (2022) Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody. Vaccine 40:40, pages 5757-5763.
Crossref
Morgane Crausaz, Guillaume Monneret, Filippo Conti, Anne-Claire Lukaszewicz, Jean-Baptiste Marchand, Perrine Martin, Geneviève Inchauspé & Fabienne Venet. (2022) A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19. Frontiers in Immunology 13.
Crossref
Laetitia Boutin, Estelle Mosca & Frédéric Iseni. (2022) Efficient Method for Generating Point Mutations in the Vaccinia Virus Genome Using CRISPR/Cas9. Viruses 14:7, pages 1559.
Crossref
Annabel T. Olson, Stephanie J. Child & Adam P. Geballe. (2022) Antagonism of Protein Kinase R by Large DNA Viruses. Pathogens 11:7, pages 790.
Crossref
María M. Lorenzo, Aitor Nogales, Kevin Chiem, Rafael Blasco & Luis Martínez-Sobrido. (2022) Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development. Microbiology Spectrum 10:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.